Federico Bussolino
#129,697
Most Influential Person Now
Researcher
Federico Bussolino's AcademicInfluence.com Rankings
Federico Bussolinoengineering Degrees
Engineering
#4395
World Rank
#5588
Historical Rank
Biomedical Engineering
#274
World Rank
#281
Historical Rank
Applied Physics
#1060
World Rank
#1087
Historical Rank
Federico Bussolinobiology Degrees
Biology
#8463
World Rank
#11540
Historical Rank
Cell Biology
#331
World Rank
#339
Historical Rank
Download Badge
Engineering Biology
Why Is Federico Bussolino Influential?
(Suggest an Edit or Addition)Federico Bussolino's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth (1992) (1350)
- Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. (1997) (1118)
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT (2002) (729)
- Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. (1999) (649)
- Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate (1989) (642)
- Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 (1999) (620)
- Cytokine regulation of endothelial cell function (1992) (602)
- Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function (2003) (581)
- Molecular mechanisms of blood vessel formation. (1997) (468)
- The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells (1996) (417)
- The release of platelet-activating factor from human endothelial cells in culture. (1983) (411)
- Cytokine regulation of endothelial cell function: from molecular level to the bedside. (1997) (404)
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) (370)
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor (1987) (338)
- Modeling the early stages of vascular network assembly (2003) (329)
- HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma (2002) (323)
- In vitro and in vivo activation of endothelial cells by colony-stimulating factors. (1991) (311)
- c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. (1999) (295)
- The molecular action of tumor necrosis factor‐α (1991) (259)
- Percolation, morphogenesis, and burgers dynamics in blood vessels formation. (2003) (255)
- Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells (2009) (254)
- Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells* (1998) (248)
- Sema4D induces angiogenesis through Met recruitment by Plexin B1. (2005) (239)
- Integrins and angiogenesis: a sticky business. (2006) (235)
- Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. (1981) (219)
- Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. (1986) (210)
- Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. (1987) (199)
- Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival (2003) (197)
- Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. (2009) (195)
- Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. (1988) (193)
- MATERNAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIA (1980) (193)
- Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 (2005) (187)
- Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. (1998) (183)
- Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. (1994) (182)
- HIV-tat protein is a heparin-binding angiogenic growth factor. (1996) (175)
- Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. (1987) (171)
- Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. (2005) (164)
- Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. (2012) (162)
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways (2009) (160)
- IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk1 (2001) (155)
- Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis (1994) (154)
- In vivo activation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSF (2002) (152)
- Production of platelet-activating factor by chick retina. (1986) (150)
- Aminopeptidase A is a functional target in angiogenic blood vessels. (2004) (145)
- Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage. (1992) (143)
- Is there a case for PAF antagonists in the treatment of ischemic states? (1989) (140)
- Cytokine regulation of endothelial cell function. (1992) (135)
- A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence (2009) (134)
- Recombinant AAV vector encoding human VEGF165 enhances wound healing (2002) (131)
- Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. (2005) (126)
- Modulation of endothelial cell functions by different molecular species of interleukin 1. (1987) (122)
- Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. (1981) (121)
- Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. (1997) (117)
- A review of vasculogenesis models (2005) (114)
- Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. (2005) (114)
- Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. (1995) (107)
- Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. (1995) (107)
- Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis (2014) (105)
- Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. (1991) (105)
- Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. (1994) (104)
- Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. (1998) (100)
- The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling (2012) (99)
- Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor (1995) (99)
- Role of cytokines and platelet-activating factor in microvascular immune injury. (1989) (97)
- Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis (1998) (96)
- Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases (1988) (96)
- Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. (1997) (95)
- Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* (1999) (95)
- PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. (1989) (95)
- Src‐mediated activation of α‐diacylglycerol kinase is required for hepatocyte growth factor‐induced cell motility (2000) (95)
- Diffusion-limited phase separation in eukaryotic chemotaxis. (2005) (93)
- Free cytoplasmic Ca++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients (1988) (92)
- CCL16 activates an angiogenic program in vascular endothelial cells. (2004) (91)
- Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. (2003) (90)
- Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. (1997) (89)
- Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. (2006) (88)
- Role of soluble mediators in angiogenesis. (1996) (88)
- Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. (1994) (88)
- Release of platelet-activating factor in systemic lupus erythematosus. (1990) (85)
- The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85β. (2012) (84)
- Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidatively-stressed and in clearance of senescent red cells. (1988) (84)
- Identification of CD36 molecular features required for its in vitro angiostatic activity (2005) (84)
- Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. (2010) (83)
- Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. (1993) (83)
- Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet- activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions (1990) (82)
- Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. (1982) (81)
- KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer (2019) (81)
- In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. (1995) (80)
- Acetylcholine‐induced production of platelet‐activating factor by human fetal brain cells in culture (1990) (79)
- Essential role of PDK1 in regulating endothelial cell migration (2007) (76)
- Platelet-Activating Factor Produced by Endothelial Cells (1995) (75)
- IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. (1988) (75)
- Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis. (2000) (74)
- Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. (2003) (73)
- Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells (2000) (73)
- A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. (1995) (72)
- Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte‐colony‐stimulating factor (1993) (72)
- Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells. (1983) (71)
- Stimulation of the Na+/H+ exchanger in human endothelial cells activated by granulocyte- and granulocyte-macrophage-colony-stimulating factor. Evidence for a role in proliferation and migration. (1989) (69)
- Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing–remitting multiple sclerosis (1999) (69)
- Type I Collagen Limits VEGFR-2 Signaling by a SHP2 Protein-Tyrosine Phosphatase–Dependent Mechanism 1 (2005) (68)
- LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. (2009) (67)
- Integration of microfluidic and cantilever technology for biosensing application in liquid environment. (2010) (66)
- Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages (2012) (64)
- Gorham‐Stout Syndrome: A Monocyte‐Mediated Cytokine Propelled Disease (2005) (64)
- Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane. (2010) (64)
- SERS active Ag nanoparticles in mesoporous silicon: detection of organic molecules and peptide–antibody assays (2012) (64)
- Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase. (2011) (64)
- Human Immunodeficiency Virus Type 1 Tat Regulates Endothelial Cell Actin Cytoskeletal Dynamics through PAK1 Activation and Oxidant Production (2004) (63)
- Modeling human tumor angiogenesis in a three-dimensional culture system. (2013) (62)
- Interactions between endothelial cells and HIV-1. (2001) (62)
- The molecular action of tumor necrosis factor-alpha. (1991) (61)
- 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner. (2012) (61)
- Biosynthesis and release of platelet-activating factor from human monocytes. (1983) (60)
- IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production1 (2003) (60)
- Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. (1990) (60)
- Expression of Angiopoietin-1 in Human Glioblastomas Regulates Tumor-Induced Angiogenesis: In Vivo and In Vitro Studies (2001) (60)
- Regulation of nitric oxide synthesis in uraemia. (1995) (59)
- Besides adhesion: new perspectives of integrin functions in angiogenesis. (2008) (59)
- Human monocyte‐derived and CD34+ cell‐derived dendritic cells express functional receptors for platelet activating factor (1997) (59)
- PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations (2018) (59)
- Liver X Receptor Activation Reduces Angiogenesis by Impairing Lipid Raft Localization and Signaling of Vascular Endothelial Growth Factor Receptor-2 (2012) (59)
- Temporal and Spatial Modulation of Rho GTPases during in Vitro Formation of Capillary Vascular Network (2003) (59)
- Differential expression of the common β and specific α chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells (1993) (59)
- Activation of diacylglycerol kinase α is required for VEGF-induced angiogenic signaling in vitro (2004) (58)
- Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. (1992) (58)
- The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions (2009) (58)
- Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor (1989) (57)
- Adaptor ShcA Protein Binds Tyrosine Kinase Tie2 Receptor and Regulates Migration and Sprouting but Not Survival of Endothelial Cells* (2004) (57)
- Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies (2017) (56)
- Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. (1988) (55)
- Neurexins and neuroligins: synapses look out of the nervous system (2011) (54)
- A Fluorescent One-Dimensional Photonic Crystal for Label-Free Biosensing Based on Bloch Surface Waves (2013) (54)
- In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis. (1991) (54)
- Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. (1992) (54)
- Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. (1991) (53)
- Integrin signaling and lung cancer (2010) (52)
- Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth. (2012) (52)
- Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. (1995) (52)
- The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination (2015) (52)
- Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. (1985) (51)
- Intravascular release of platelet activating factor in children with sepsis. (1987) (51)
- Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. (2000) (51)
- Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores (2011) (50)
- Semaphoring vascular morphogenesis. (2006) (50)
- Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer (2014) (50)
- HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment (2001) (49)
- Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer. (2017) (49)
- Acetylcholine and Dopamine Promote the Production of Platelet Activating Factor in Immature Cells of Chick Embryonic Retina (1988) (49)
- Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments. (1980) (49)
- Diacylglycerol kinase-α phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility (2008) (48)
- Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia (2011) (47)
- Development of microcantilever-based biosensor array to detect Angiopoietin-1, a marker of tumor angiogenesis. (2010) (47)
- Common cues in vascular and axon guidance. (2004) (46)
- Streptokinase Induces Intravascular Release of Platelet‐Activating Factor in Patients With Acute Myocardial Infarction and Stimulates Its Synthesis by Cultured Human Endothelial Cells (1993) (46)
- Angiogenesis: prognostic significance in laryngeal cancer. (1998) (45)
- Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. (2005) (44)
- A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6 (2012) (44)
- BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer (2016) (44)
- Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. (1994) (44)
- Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. (1997) (43)
- Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. (1986) (42)
- Class 3 semaphorins: physiological vascular normalizing agents for anti‐cancer therapy (2013) (42)
- TFEB controls vascular development by regulating the proliferation of endothelial cells (2018) (41)
- Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. (1991) (41)
- Tumor progression: the neuronal input. (2018) (40)
- Protein Kinase D1 Regulates VEGF‐A‐Induced αvβ3 Integrin Trafficking and Endothelial Cell Migration (2010) (40)
- Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. (1990) (40)
- Platelet-activating factor (PAF) induces the early tyrosine phosphorylation of focal adhesion kinase (p125FAK) in human endothelial cells. (1996) (40)
- Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. (2013) (40)
- Semaphorins and tumor angiogenesis (2009) (39)
- Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells (1993) (39)
- Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase (1995) (39)
- Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment (2018) (39)
- MicroRNA-mediated regulatory circuits: outlook and perspectives (2017) (39)
- PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction (2014) (38)
- Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. (2019) (37)
- Nervous vascular parallels: axon guidance and beyond. (2011) (37)
- Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1). (1989) (36)
- Platelet-activating factor production by human fetal microglia. Effect of lipopolysaccharides and tumor necrosis factor-alpha. (1995) (36)
- Comparative genome analysis of the neurexin gene family in Danio rerio: insights into their functions and evolution. (2007) (35)
- Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. (1984) (35)
- Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock. (1992) (35)
- Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinical models of colorectal cancer (2012) (34)
- Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. (1987) (34)
- Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells. (1999) (33)
- Unraveling the influence of endothelial cell density on VEGF-A signaling. (2012) (33)
- Neuroligin 1 Induces Blood Vessel Maturation by Cooperating with the α6 Integrin* (2014) (33)
- Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis (2008) (32)
- Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. (1992) (31)
- Endothelial cells express the interleukin-1 receptor type I (1991) (30)
- Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells. (1994) (30)
- Human endothelial cells expressing polyoma middle T induce tumors (2000) (30)
- Real-time monitoring of cell protrusion dynamics by impedance responses (2015) (29)
- Modulation of neurite outgrowth in neuroblastoma cells by protein kinase C and platelet-activating factor. (1991) (29)
- Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement* (2007) (29)
- Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation (1982) (29)
- A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis (2020) (29)
- VEGF blockade enhances the antitumor effect of BRAFV 600E inhibition (2016) (28)
- Insulin‐like growth factor binding protein‐3 is overexpressed in endothelial cells of mouse breast tumor vessels (2003) (27)
- On the Use of Stochastic Petri Nets in the Analysis of Signal Transduction Pathways for Angiogenesis Process (2009) (27)
- Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. (1986) (27)
- Platelet activating factor induces dopamine release in PC-12 cell line. (1988) (27)
- Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. (1983) (26)
- Release of platelet-activating factor in human leukemia. (1985) (26)
- MRCKα is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion (2018) (26)
- Involvement of a serine protease in the synthesis of platelet‐activating factor by endothelial cells stimulated by tumor necrosis factor‐α or interleukin‐1α (1994) (26)
- An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. (1990) (25)
- Biological Aspects of Tumour Angiogenesis (2003) (25)
- Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative. Effect on the motility of vascular endothelial cells. (2000) (25)
- Stimulation of platelet-activating factor synthesis in human endothelial cells by activation of the de novo pathway. Phorbol 12-myristate 13-acetate activates 1-alkyl-2-lyso-sn-glycero-3-phosphate:acetyl-CoA acetyltransferase and dithiothreitol-insensitive 1-alkyl-2-acetyl-sn-glycerol:CDP-choline ch (1991) (25)
- Tat‐induced platelet‐activating factor synthesis contributes to the angiogenic effect of HIV‐1 Tat (2001) (25)
- Sema 4 D induces angiogenesis through Met recruitment by Plexin B 1 (2005) (25)
- Acute renal failure in preeclampsia-eclampsia. (1987) (24)
- Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. (2004) (24)
- Bloch surface wave label-free and fluorescence platform for the detection of VEGF biomarker in biological matrices (2018) (24)
- Vasculogenic potential of long term repopulating cord blood progenitors (2004) (24)
- Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. (1983) (24)
- Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine. (1991) (24)
- Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells (2001) (24)
- SPAD aptasensor for the detection of circulating protein biomarkers. (2015) (24)
- Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 (2019) (24)
- Dictyostelium cells produce platelet-activating factor in response to cAMP. (1991) (23)
- Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. (1993) (23)
- Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma (2019) (22)
- Measurement of phagocytosis utilizing [14C]cyanate‐labelled human red cells and monocytes (1987) (22)
- Characterization of kaposis sarcoma-derived cell-cultures from an epidemic and a classic case. (1992) (22)
- Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors. (2007) (22)
- Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation. (1980) (22)
- Recognition signals for phagocytic removal of favic, malaria-infected and sickled erythrocytes. (1991) (21)
- Cytoadherence of Plasmodium falciparum-Infected Erythrocytes Is Mediated by a Redox-Dependent Conformational Fraction of CD361 (2001) (21)
- Multifaceted activities of transcription factor EB in cancer onset and progression (2020) (21)
- Fluorescence anisotropy analysis of protein-antibody interaction (2009) (20)
- Actions of molecules which regulate hemopoiesis on endothelial cells: memoirs of common ancestors? (1994) (20)
- Platelet-activating factor production occurs through stimulation of cholinergic and dopaminergic receptors in the chick retina. (1989) (20)
- Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. (1993) (20)
- The Synaptic Proteins &bgr;-Neurexin and Neuroligin Synergize With Extracellular Matrix-Binding Vascular Endothelial Growth Factor A During Zebrafish Vascular Development (2012) (20)
- Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. (1990) (20)
- Cytokine mRNA expression by cultured rat mesangial cells after contact with environmental lectins. (1993) (20)
- Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin‐1 and Flk‐1 (2009) (19)
- Na+/H+ antiporter has different properties in human B lymphocytes according to CD5 expression and malignant phenotype (1991) (18)
- Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1. (1990) (18)
- Endothelial cells express the interleukin-1 receptor type I. (1991) (18)
- Role of the microenvironment in the specification of endothelial progenitors derived from embryonic stem cells. (2010) (18)
- Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP. (1980) (18)
- The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients. (2015) (18)
- Optimized design and fabrication of a microfluidic platform to study single cells and multicellular aggregates in 3D (2017) (17)
- Characterization of the neuroligin gene family expression and evolution in zebrafish (2010) (16)
- Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. (2018) (16)
- In vivo priming of human normal neutrophils by granulocyte‐macrophage colony stimulating factor: effect on the production of platelet activating factor (1990) (16)
- Tumor Necrosis Factor-α in Airway Secretions from Cystic Fibrosis Patients Upregulate Endothelial Adhesion Molecules and Induce Airway Epithelial Cell Apoptosis: Implications for Cystic Fibrosis Lung Disease (2008) (15)
- Protective Effects of L‐659,989, a Platelet‐Activating Factor Receptor Antagonist, in Myocardial Ischemia and Reperfusion in Rats (1994) (15)
- Simplification of a complex signal transduction model using invariants and flow equivalent servers (2011) (15)
- Class 3 semaphorin in angiogenesis and lymphangiogenesis. (2014) (15)
- Differential regulation of neurexin at glutamatergic and GABAergic synapses (2013) (15)
- Semaphorins in cardiovascular medicine. (2014) (15)
- Hydrogel-Terminated Photonic Crystal for Label-Free Detection of Angiopoietin-1 (2016) (14)
- Anti‐tumor activity of cytokines against opportunistic vascular tumors in mice (1996) (14)
- Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity (2016) (14)
- Platelet activating factor modulates signal transduction in Dictyostelium. (1993) (14)
- Multiple roles of platelet-activating factor in the nervous system (1995) (14)
- Semaphorins and tumor angiogenesis (2009) (13)
- GM‐CSF and phorbol esters modulate GM‐CSF receptor expression by independent mechanisms (1991) (12)
- Human α-thrombin induces phosphoinositide turnover and Ca2+ movements in cultured human umbilical vein endothelial cells (1989) (12)
- SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets (2019) (12)
- A new computational approach to analyze human protein complexes and predict novel protein interactions (2007) (12)
- PDK1 regulates focal adhesion disassembly by modulating endocytosis of &agr;v&bgr;3 integrin (2015) (12)
- The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger for the immune-induced PMN aggregation. (1980) (11)
- Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease. (2008) (11)
- Involvement of cytokines and platelet-activating factor in renal pathology. (1990) (11)
- TFEB Signalling-Related MicroRNAs and Autophagy (2021) (10)
- Symmetry breaking mechanism for epithelial cell polarization. (2009) (10)
- Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. (2001) (10)
- A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2. (2013) (10)
- Angiogenesis: a balancing act between integrin activation and inhibition? (2009) (10)
- The biological basis for antiangiogenic therapy. (2000) (10)
- [Laryngeal cancer and angiogenesis]. (1996) (10)
- Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase. (1989) (9)
- Activation of endothelial guanylate cyclase inhibits cellular reactivity. (1995) (9)
- Role of Na+/H+ exchange in the granulocyte‐macrophage colony‐stimulating factor‐dependent growth of a leukemic cell line (1990) (9)
- Evidence for a role of the Na+/H+ exchanger in the colony‐stimulating‐factor‐induced ornithine decarboxylase activity and proliferation of the human cell line M‐07e (1990) (9)
- VEGF-Mediated Signal Transduction in Tumor Angiogenesis (2017) (9)
- Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. (1983) (9)
- The V1/V2 loop of HIV‐1 gp120 is necessary for Tat binding and consequent modulation of virus entry (2013) (9)
- Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program (2017) (8)
- Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. (2011) (8)
- Essential role of PDK 1 in regulating endothelial cell migration (2007) (8)
- Diamide enhances phagocytosis of human red cells in a complement- and anti band 3 antibody-dependent process. (1987) (8)
- Removal of constitutive and inducible nitric oxide synthase-active compounds in a modified hemodiafiltration with on-line production of substitution fluid: the contribution of convection and diffusion (1996) (8)
- Platelet-activating factor and angiogenesis. (1996) (7)
- Regulation of platelet-activating factor synthesis by acetyl-coenzyme A. (1990) (7)
- Activation of JAK 2 in Human Vascular Endothelial Cells by Granulocyte-Macrophage Colony-Stimulating Factor (1997) (7)
- Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection. (1999) (7)
- Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. (2003) (7)
- Erratum: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function (2003) (7)
- Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. (2001) (6)
- Role of platelet activating factor in the adhesion process of polymorphonuclear neutrophils to endothelial cells. (1991) (6)
- Platelet-activating factor phosphatidate, but not platelet-activating factor, is a powerful calcium ionophore in the human red cell. (1984) (6)
- A transient kinetic study between signaling proteins: the case of the MEK–ERK interaction (2011) (6)
- A Simulation Environment for Directional Sensing as a Phase Separation Process (2007) (6)
- Emerging lymphae for the fountain of life (2013) (6)
- Embryonic cleavage modeling as a computational approach to sphere packing problem. (2007) (6)
- IL-12-dependent innate immunity arrests endothelial cells in G0–G1 phase by a p21Cip1/Waf1-mediated mechanism (2012) (6)
- CCL 16 activates an angiogenic program in vascular endothelial cells (2003) (6)
- TFEB controls integrin-mediated endothelial cell adhesion by the regulation of cholesterol metabolism (2022) (6)
- Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy (2016) (6)
- Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis (2022) (5)
- Endothelium-derived modulators of leukocyte function (1991) (5)
- Stable interaction between (cid:1) 5 (cid:2) 1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 (2005) (5)
- Effect of granulocyte-macrophage colony-stimulating factor on endothelial cells. (1991) (5)
- Genetic perturbation of IFN-α transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis (2020) (5)
- Microvessel count is predictive of patients' survival in laryngeal squamous‐cell carcinoma (1996) (5)
- Modulation of Angiopoietin 2 release from endothelial cells and angiogenesis by the synaptic protein Neuroligin 2. (2018) (5)
- The Oncogene Transcription Factor EB Regulates Vascular Functions (2021) (5)
- Mature endothelium and neurons are simultaneously derived from embryonic stem cells by 2D in vitro culture system (2011) (5)
- Three-dimensional in vitro assay of endothelial cell invasion and capillary tube morphogenesis. (2015) (5)
- Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha. (1994) (5)
- Tumoral Neuroligin 1 Promotes Cancer–Nerve Interactions and Synergizes with the Glial Cell Line-Derived Neurotrophic Factor (2022) (4)
- Evidence for a role of platelet activating factor in hypovolemic shock in the rat. (1994) (4)
- Human GM-CSF in vivo: identification of the target cells and of their kinetics of response. (1990) (4)
- HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction (2020) (4)
- miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1 (2021) (4)
- PAF enhances erytrophagocytic activity of human monocytes by the protein kinase C dependent phosphorylation of C3b receptor (CR1). Role of PAF receptor antagonists (1988) (4)
- HAEMOLYTIC ABORTIVE SYNDROME (1983) (4)
- The role of redox system in metastasis formation (2021) (4)
- Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation. (1982) (4)
- Platelet arachidonic acid metabolism in patients with cardiovascular disorders. (1988) (3)
- Platelet-activating factor (PAF), a mediator of platelet aggregation. Effect of corticosteroids on PAF-induced platelet aggregation. (1980) (3)
- Tumor progression in osteosarcoma (OS): Role of the chemokine receptor CXCR4 and of its ligand stromal-cell derived factor 1 (SDF-1). (2004) (3)
- Neuroligin 1 induces blood vessel maturation by cooperating with the α6 integrin. (2014) (3)
- Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma (2021) (3)
- Small molecule approaches for promoting ischemic tissue vascularization. (2006) (3)
- An Electrical Impedance-Based Method for Quantitative Real-Time Analysis of Semaphorin-Elicited Endothelial Cell Collapse. (2017) (3)
- Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations (2021) (3)
- The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway (2022) (3)
- The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes. (1982) (2)
- Characterization of the murine monoclonal antibody NL07 specific for the human thrombospondin receptor (CD36 molecule). (1991) (2)
- SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma (2022) (2)
- Genetic mapping1 of the mouse homologue of the human angiopoietin-1 gene (Agpt) to mouse chromosome 9E2 by in situ hybridization (2000) (2)
- Role of TGFβ1 and WNT6 in FGF2 and BMP4-driven endothelial differentiation of murine embryonic stem cells (2021) (2)
- Bloch Surface Waves on Dielectric Photonic Crystals for Biological Sensing (2014) (2)
- Specific binding of 1-[3H]-O-alkyl-2-acetyl-sn-glyceryl-3-phosphoryl choline (platelet-activating factor, PAF) by human polymorphonuclear neutrophils (1984) (2)
- Recent Advances in Angiogenesis and Antiangiogenesis (2018) (2)
- Transcription factor EB controls both motogenic and mitogenic cell activities (2022) (2)
- Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: The inhibitory effect of prostacyclin (PGI2) (1981) (2)
- Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. (2022) (2)
- VRG: A database of vascular dysfunctions related genes (2008) (2)
- IL-12-dependent innate immunity arrests endothelial cells in G0–G1 phase by a p21Cip1/Waf1-mediated mechanism (2012) (2)
- Redox metabolism regulation in normal and metabolically altered human platelets. (1985) (2)
- PDK 1 regulates focal adhesion disassembly through modulation of 1 v 3 integrin endocytosis (2014) (1)
- Is the increased erythrophagocytosis of malaria-infected variant erythrocytes due to early expression of normal senescence markers or to the formation of new and specific removal markers? (1990) (1)
- Removal of constitutive and inducible nitric oxide synthase active compounds by paired filtration dialysis (1998) (1)
- Abstract A13: Endothelial podosome rosettes regulate vascular branching in tumor angiogenesis (2015) (1)
- Why is plasma infusion useful in hemolytic uremic syndrome? (1984) (1)
- Lymphocyte-Endothelial Cell Cross-Talk and Angiogenesis Depends on IL-12 Inhibition of Endothelial Cell Functions (2001) (1)
- Protein kinase C activation in murine endothelioma cell lines containing middle T antigen stimulated by platelet-activating factor. (1992) (1)
- Tat – Human Immunodeficiency Virus-1 Induces Human Monocyte Chemotaxis by Activation of Vascular Endothelial Growth Factor Receptor-1 (1997) (1)
- Platelet-activating factor (PAF) release from rat peritoneal cells, evidence for mastocyte-macrophage cooperation. (1980) (1)
- Unbalance between production and catabolism of platelet-activating factor (PAF) in human pathology. Studies of PAF acetylhydrolase (AH) in systemic lupus erythematosus (SLE) (1987) (1)
- PLATELET-ACTIVATING FACTOR IS INHIBITED BY PLASMA at-PROTEINASE INHIBITOR OR at-ANTICHYMOTRYPSIN AND IS STIMULATED BY PROTEINASES (1988) (1)
- MRS-AACR Joint Conference on Metastasis 2010 (2010) (1)
- Erratum: Semaphorins and tumor angiogenesis (Angiogenesis DOI 10.1007/s10456-009-9138-4) (2009) (1)
- SYNTHESIS AND RELEASE OF PLATELET-ACTIVATING FACTOR IS INHIBITED BY PLASMA at-PROTEINASE INHIBITOR OR at-ANTICHYMOTRYPSIN AND IS STIMULATED BY PROTEINASES BY (2003) (1)
- Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. Vol. 278 (2003) 50702-50713 (2004) (1)
- Erratum: Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism (Cancer Research (April 1, 2003)(1500-1507)) (2003) (1)
- S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells (1993) (1)
- Long Non-Coding RNA LINC02802 Regulates In Vitro Sprouting Angiogenesis by Sponging microRNA-486-5p (2022) (1)
- Target cells for GM-CSF and kinetics of response. (1990) (1)
- Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer (2013) (1)
- Platelet-activating Factor Enhances Complement-dependent Phagocytosis of Diamide-treated Erythrocytes by Human Monocytes through Activation of Protein Kinase C and Phosphorylation of Complement Receptor Type One ( CRl ) * (2001) (0)
- Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia (2011) (0)
- Role of TGFβ1 and WNT6 in FGF2 and BMP4-driven endothelial differentiation of murine embryonic stem cells (2021) (0)
- An Overview of the Molecular Cues and Their Intracellular Signaling Shared by Cancer and the Nervous System: From Neurotransmitters to Synaptic Proteins, Anatomy of an All-Inclusive Cooperation (2022) (0)
- Meeting Report The biological basis for antiangiogenic therapy (2000) (0)
- Fourth European Workshop on Inflammation Wilrijk March 1982 (1982) (0)
- Pathophysiology of Inflammation (1981) (0)
- Murine monoclonal antibody (MoAb) NL07 specific for the human CD36 receptor (1990) (0)
- An extra-cellular protein signature of metastatic colon cancer (2007) (0)
- Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis (2009) (0)
- Platelet-activating factor induces the release of tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion (SAO) shock (1994) (0)
- Abstract A164: Targeting PDK1 in breast cancer: Kinase-dependent regulation of tumor growth and kinase-independent regulation of cell migration and invasion. (2013) (0)
- In vitro spasmogenic effect on rabbit lung tissue of 1-O-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor): Specific desensitization afterin vivo infusion (1983) (0)
- SERS active Ag nanoparticles in mesoporous silicon: from biosensing to single molecule detection (2012) (0)
- PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations (2018) (0)
- Dictyostelium cells synthesize platelet-activating factor in response to cAMP (1990) (0)
- Tumor Necrosis Factor α Induces PAF-Dependent Angiogenesis (1998) (0)
- Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. (2013) (0)
- Growth of endothelial cell networks and Burgers dynamics (2002) (0)
- Mining Genomes of Actinobacteria (2022) (0)
- Abstract 2355: Transcription factor EB modulates fibrotic response in pancreatic ductal adenocarcinoma (2023) (0)
- vascular parallels: axon guidance and beyond (0)
- Non-Small Cell Lung Cancer Survival Estimation Through multi-omic two-layer SVM: a Multi-Omics and Multi-Sources Integrative Model (2023) (0)
- Targeting the extracellular signature of metastatic colon cancers (2008) (0)
- Nitric oxide in the pathogenesis of Guillain-Barré syndrome (2000) (0)
- [Hormonal modulation of inflammation]. (1980) (0)
- Abstract 530: PDK1 regulates cell migration and 3D invasion of breast tumor cells by a kinase independent mechanism (2015) (0)
- Human Endothelial Cells Produce Platelet Activating Factor in Response to Interleukin 1 (1987) (0)
- Growth Factor-A Expression in Macrophages Effect by Enhancing Vascular Endothelial Semaphorin 4A Exerts a Proangiogenic (2012) (0)
- 2017 Reviewer Acknowledgment (2018) (0)
- Platelet-activating factor, a mediator of platelet aggregation: Effect of corticosteroids (1981) (0)
- Abstract 1163: Microenvironment targets in KRASmutated metastatic colorectal cancer (2014) (0)
- FAP activates rat macrophages and enhances complement-mediateed phagocytes (1987) (0)
- Revised guidelines for authors of gene mapping reports (2000) (0)
- Abstract 13272: MiR-200c-5p Regulates Epithelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1 (2019) (0)
- The TFEB-TGIF1 axis regulates EMT in mouse epicardial cells (2022) (0)
- Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia (2011) (0)
- Contents Vol. 87, 1999 (2000) (0)
- Structure, expression, and alternative splicing characterization of zebrafish Neurexin genes (2007) (0)
- The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway (2022) (0)
- Lymphomononuclear Cell Recruitment Vascular Permeability and HIV-1 Tat Protein Stimulates In Vivo (2013) (0)
- Levels of platelet-activating factor in cerebrospinal fluid and plasma of patients with relapsing-remitting multiple sclerosis (1999) (0)
- Microcantilever Biosensors: using a nanomechanical resonator to quantify specific molecular targets (2007) (0)
- Abstract 1015: Dual BRAF and VEGFA targeting in melanoma elicits antitumor immune response that is enhanced by PD-1 blockade (2018) (0)
- 126 POSTER Novel phage display-derived peptides for tumor- and vascular- targeted therapies against neuroblastoma (2008) (0)
- Interleukin 1 induces biosynthesis of platelet activating factor in human endothelial cells by deacylation/reacetylation process (1987) (0)
- Plexins and neuropilins regulate integrin conformation and trafficking in endothelial cells (2009) (0)
- 36 ofRedox-Dependent Conformational Fraction-Infected Erythrocytes Is Mediated by a Plasmodium falciparum Cytoadherence of and (2001) (0)
- Increased Free Cytoplasmic Ca++in Cultured Muscle Cells from Patients Affected by Duchenne Muscular Dystrophy (DMD) (1987) (0)
- [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction]. (1980) (0)
- 25 Molecular mechanisms of angiogenesis associated to kaposi's sarcoma (1995) (0)
- Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. (2011) (0)
- PLEIOTROPIC EFFECT OF INTERLEUKIN-1 ON ENDOTHELIAL CELLS (1987) (0)
- Role of Endothelium-Derived Platelet Activating Factor in Biological Responses to Thrombolytic Agents (1996) (0)
- Chick retina generates platelet-activating factor. (1987) (0)
- Role of Endothelium-Derived Platelet Activating Factor in Biological Responses to Thrombolytic Agents (1996) (0)
- Comparative Genomics of Actinobacteria (2022) (0)
- [GM-CSF: target cells and their response kinetics]. (1989) (0)
- Detection of Angiogenic Growth Factor by Microcantilever Biosensors (2011) (0)
- Role of Na+/H+ exchange in thrombin-mediated activation of human endothelial cells in culture (1988) (0)
- The involvement of integrins in the fine tuning of Angiopoietin-1 / Tie 2 signalling (2010) (0)
- [Platelet mediators of vascular permeability and phlogosis]. (1980) (0)
- endothelial cells with acute myocardial infarction and stimulates its synthesis by cultured human Streptokinase induces intravascular release of platelet-activating factor in patients (2011) (0)
- endothelial cell activation by Axl tyrosine kinase receptor mediated - Inhibition of vascular endothelial growth factor receptor 2 (2013) (0)
- Human alpha-thrombin induces phosphoinositide turnover and Ca2+ movements in cultured human umbilical vein endothelial cells. (1989) (0)
- Regulation of integrin function controls angiogenic remodeling (2009) (0)
- Immune-induced leucopenia. A role for the aggregation of polymorphonuclear neutrophils in systemic lupus erythematosus (SLE). (1981) (0)
- Abstract 4052: Targeting PDK1 in breast cancer: kinase-dependent regulation of tumor growth and kinase-independent regulation of cell migration and invasion (2014) (0)
- Transcriptome Profiles of Streptomyces sp. (2022) (0)
- PAF acether phosphatidate, but not PAF-acether, is a powerful calcium ionophore in the human red cell (1984) (0)
- marrow endothelial cells of patients with multiple myeloma Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone (2011) (0)
- Receptor-1 Chemotaxis by Activation of Vascular Endothelial Growth Factor Human Immunodeficiency Virus-1 Induces Human Monocyte − Tat (1997) (0)
- Author response: A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis (2019) (0)
- Abstract B17: VEGF removal delays the onset of acquired resistance to target therapy and increases the efficacy of immune checkpoint inhibitors in BRAF-mutated melanoma (2020) (0)
- Erythrocyte Stages of Plasmodium s Exhibit a High Nitric Oxide Synthase ( NOS ) . Activity and Release an NOS-inducing Soluble Factor (2003) (0)
- In vitro and in vivo methodologies to study vascular cell disfunction in aging (1992) (0)
- Peptides and their metastasis-specific diagnostic and therapeutic applications (2006) (0)
- Abstract 3394: Bevacizumab enhances the antitumor effect of BRAFV600E inhibition in colorectal and melanoma xenograft models (2016) (0)
- Platelet and plasma platelet-activating factor in sepsis and myocardial infection. (1994) (0)
- Correction to: The role of redox system in metastasis formation (2021) (0)
- [Prostacyclin (PGI2) inhibits neutropenia induced by immune complexes]. (1982) (0)
- SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma (2022) (0)
- Endothelial cells and inflammation: The role of PAF, monokines and circulating cells (1987) (0)
- Abstract SY41-04: Targeting Semaphorin 3A: A new tool to normalize tumor vasculature and to overcome the evasive resistance to the anti-angiogenic therapy (2012) (0)
- Letter to the editorial board (1994) (0)
- A Computational Model for Eukaryotic Directional Sensing (2006) (0)
- 2016 Reviewer Acknowledgment (2017) (0)
- Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages (2011) (0)
- Abstract 4807: Zoledronic acid overcomes the resistance to the anti-angiogenic therapy and normalizes tumor vessels by switching from a M2- to a M1-like macrophages phenotype in a mouse model of spontaneous cervical cancer (2014) (0)
- Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity (2016) (0)
- E15.5 Mouse Embryo Micro-CT Using a Bruker Skyscan 1172 Micro-CT (2023) (0)
- Supplemental Maione F OSC tumor angiogenesis SciRep 2015 (2015) (0)
- Contents, Vol. 24, 1987 (1987) (0)
- Targeted nanomedicines for applications in preclinical cancer models (2018) (0)
- Subject Index Vol. 87, 1999 (2000) (0)
- Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy (2021) (0)
- Corrigendum to “Genetic perturbation of IFN-α transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis” [Comput Struct Biotechnol J. 2020 Dec 2;18:3977–3986. doi: https://doi.org//10.1016/j.csbj.2020.11.048. eCollection 2020] (2021) (0)
- 2-31-12 Role of platelet activating factor in the pathogenesis of multiple sclerosis (1997) (0)
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) (0)
- Obituary: Graziella Persico (2007) (0)
- The tissue-specific transcriptional landscape underlines the involvement of endothelial cells in health and disease. (2023) (0)
- Phase Separation in Eukaryotic Directional Sensing (2007) (0)
- Laboratory Assistant Suite platform for biomedical data management and integration (2011) (0)
- Release of Platelet-Activating Factor from Human Leukaemic Cell Lines (1984) (0)
- Metalloproteinase-9 Production Cell-Lymphocyte Network: Effect on IL-12 Regulates an Endothelial (2003) (0)
- Does p 53 mutant R 273 H show dominant negative or gain-of-function activity in mediating sensitivity or resistance to anti-cancer drugs ? ” (2010) (0)
- Human Arterial Ring Assay: an ex vivo sprouting angiogenesis model for anti-angiogenic drug screening and functional genomic studies (2015) (0)
- Platelet-activating factor dependent-, arachidonate/thromboxane A2 independent-polymorphonuclear neutrophils aggregation (1980) (0)
- [Production of PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in the chick retina during embryogenesis]. (1988) (0)
- Role of Inflammatory Mediators in Angiogenesis (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Federico Bussolino?
Federico Bussolino is affiliated with the following schools:
